- Home
- BMR vs INMB Comparison
BMR vs INMB Comparison
Compare BMR & INMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BMR
- INMB
- Stock Information
- Founded
- BMR 2009
- INMB 2015
- Country
- BMR Israel
- INMB United States
- Employees
- BMR N/A
- INMB N/A
- Industry
- BMR Computer Software: Prepackaged Software
- INMB Biotechnology: Pharmaceutical Preparations
- Sector
- BMR Technology
- INMB Health Care
- Exchange
- BMR Nasdaq
- INMB Nasdaq
- Market Cap
- BMR 47.4M
- INMB 49.2M
- IPO Year
- BMR 2023
- INMB 2019
- Fundamental
- Price
- BMR $2.74
- INMB $1.87
- Analyst Decision
- BMR
- INMB Hold
- Analyst Count
- BMR 0
- INMB 3
- Target Price
- BMR N/A
- INMB $4.30
- AVG Volume (30 Days)
- BMR 230.9K
- INMB 349.2K
- Earning Date
- BMR 08-13-2025
- INMB 10-30-2025
- Dividend Yield
- BMR N/A
- INMB N/A
- EPS Growth
- BMR N/A
- INMB N/A
- EPS
- BMR N/A
- INMB N/A
- Revenue
- BMR $3,131,000.00
- INMB $50,000.00
- Revenue This Year
- BMR $21.21
- INMB $264.29
- Revenue Next Year
- BMR N/A
- INMB $9,819.61
- P/E Ratio
- BMR N/A
- INMB N/A
- Revenue Growth
- BMR 5.96
- INMB N/A
- 52 Week Low
- BMR $1.86
- INMB $1.71
- 52 Week High
- BMR $6.59
- INMB $11.64
- Technical
- Relative Strength Index (RSI)
- BMR 44.22
- INMB 45.15
- Support Level
- BMR $2.72
- INMB $1.79
- Resistance Level
- BMR $2.90
- INMB $1.95
- Average True Range (ATR)
- BMR 0.16
- INMB 0.10
- MACD
- BMR -0.01
- INMB 0.01
- Stochastic Oscillator
- BMR 28.72
- INMB 46.00
About BMR Beamr Imaging Ltd.
Beamr Imaging Ltd is a video technology and image science software company. It is an innovator of video encoding, transcoding, and optimization solutions that enable high quality, performance, and unmatched bitrate efficiency for video and images. The company is conducted through one operating segment, the optimization technology for video and photo compression. The company operates in Israel, the United States, and the rest of the world, it derives a majority of its revenue from the United States.
About INMB INmune Bio Inc. Common stock
INmune Bio Inc is a clinical-stage biotechnology company. It is engaged in the development of new immunotherapies that reprogram a patient's innate immune system to allow immune system to fight cancer. The company's pipeline products include INKmune, INBO3, XPro1595, LIVNate, and others.